According to Curevac's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 28.5298. At the end of 2022 the company had a P/S ratio of 16.0.
Year | P/S ratio | Change |
---|---|---|
2022 | 16.0 | -70.31% |
2021 | 53.8 | -79.2% |
2020 | 259 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |